View from Brussels

Feb 01, 2016
Applied Clinical Trials
Incoherencies in Europe’s drug-access arrangements raise questions, debate.
Dec 22, 2015
Applied Clinical Trials
Despite orphan-drug R&D and approval being all the rage, issues such as patient access could leave these treatments out in the rain.
Oct 01, 2015
Applied Clinical Trials
Several initiatives are focused on integrating biomarkers and personalized medicine techniques into studies.
Aug 01, 2015
Applied Clinical Trials
Officials tackle such areas as patient access and personalized medicine.
Jun 01, 2015
Applied Clinical Trials
The tone of agency’s annual report contrasts its recent candid stance on regulatory vision for Europe.
Apr 01, 2015
Applied Clinical Trials
Media rebuke of Europe’s Innovative Medicines Initiative thrusts debate into the public arena.
Feb 01, 2015
Applied Clinical Trials
While such discussions have advanced in Europe, two key omissions from the dialogue may limit any real changes.
Jan 02, 2015
Applied Clinical Trials
Patients in Europe have been increasingly vocal in their demands for engagement in drug development and regulatory processes—and they have been increasingly effective.
Dec 01, 2014
Applied Clinical Trials
In a health policy world where competition for profile is tough, a vacuum at the top is a serious disadvantage.
Oct 01, 2014
Applied Clinical Trials
By Applied Clinical Trials Editors
Reshuffling to heavily impact life sciences policy in Europe.
native1_300x100
lorem ipsum